I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Characteristics of the study population:
Yoshikazu Tateai
;
Kazuyoshi Kawakami
;
Minori Teramae
...
doi:10.1371/journal.pone.0294320.t001. , 2023
Link:
https://doi.org/10.1371/journal.pone.0294320.t001
RT Journal T1
Characteristics of the study population
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_24575136&Exemplar=1&LAN=DE A1 Yoshikazu Tateai A1 Kazuyoshi Kawakami A1 Minori Teramae A1 Naoki Fukuda A1 Takashi Yokokawa A1 Kazuo Kobayashi A1 Naoki Shibata A1 Wataru Suzuki A1 Hisanori Shimizu A1 Shunji Takahashi A1 Masato Ozaka A1 Naoki Sasahira A1 Satoko Hori A1 Masakazu Yamaguchi YR 2023 K1 Biophysics K1 Medicine K1 Cell Biology K1 Biotechnology K1 Developmental Biology K1 Cancer K1 Mental Health K1 Infectious Diseases K1 Virology K1 Chemical Sciences not elsewhere classified K1 world clinical practice K1 pharmaceutical outpatient clinic K1 foot skin reactions K1 august 31 2021 K1 cancer institute hospital K1 patient took lenvatinib K1 day cycle divided K1 unresectable thyroid cancer K1 refractory thyroid cancer K1 unresectable hepatocellular carcinoma K1 prescribed 28 doses K1 identify factors associated K1 6 % K1 followed K1 6 %) K1 evaluate lenvatinib adherence K1 median adherence rate K1 xlink "> lenvatinib K1 55 thyroid cancer K1 lenvatinib adherence rate K1 thyroid cancer K1 xlink "> K1 hepatocellular carcinoma K1 factors associated K1 lenvatinib adherence K1 cancer research K1 adherence rate K1 treatment cycle K1 mainly associated K1 first cycle K1 treat radioiodine K1 started treatment K1 pill counting K1 major reason K1 japanese foundation K1 bleeding events K1 97 incidents JF doi:10.1371/journal.pone.0294320.t001 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0294320.t001 DO https://doi.org/10.1371/journal.pone.0294320.t001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)